A. Michalak et Ia. Qureshi, TISSUE ACYLCARNITINE AND ACYL-COENZYME-A PROFILES IN CHRONICALLY HYPERAMMONEMIC MICE TREATED WITH SODIUM BENZOATE AND SUPPLEMENTARY L-CARNITINE, Biomedicine & pharmacotherapy, 49(7-8), 1995, pp. 350-357
Citations number
41
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
The aim of the present study, was to establish the hepatic profile of
acyl-coenzyme A (acyl-CoA) in relation to the hepatic profile of acylc
arnitines in chronically hyperammonemic spf mice (hereditary deficienc
y in ornithine transcarbamylase) treated with sodium benzoate alone or
in combination with L-carnitine. The muscular profile of the acylcarn
itines and the stability of sarcolemma were also assessed in the same
mice. Following administration of sodium benzoate, we observed decreas
es in hepatic total and free coenzyme A and in acetyl-CoA, which was a
ccompanied by an increase in hepatic acyl-CoA. This treatment also res
ulted in increased free carnitine, decreased total carnitine, and decr
eased short and medium chain acylcarnitines in the liver. Increases in
plasma creatine kinase levels, muscular free, total, and in short and
medium chain acylcarnitines were also observed in this treatment grou
p. In mice receiving a combination of sodium benzoate and L-carnitine,
increases in free and total coenzyme A, acetyl-CoA and in free, total
and esterified hepatic carnitines were observed. In this treatment gr
oup, the plasma level of creatine kinase was found to be reduced, whil
e the free muscular carnitine was increased. Our results indicate that
sodium benzoate is implicated in the decrease of total hepatic coenzy
me A, through either an inhibition of CoA synthesis or activation of i
ts degradation. The inhibition distribution of hepatic coenzyme-A and
of hepatic and muscular carnitine (free or esterified) is altered foll
owing administration of sodium benzoate which results in a further des
tabilization of the sarcolemma induced by hyperammonemia. Supplemental
treatment with L-carnitine was shown to have a positive effect by inc
reasing hepatic coenzyme A and carnitine levels and restoring the stab
ility of the sarcolemma caused by the treatment of sodium benzoate alo
ne.